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Abstract 
Homocystinuria is an inborn error of metabolism characterized by plasma 
homocysteine levels up to 500 µM, premature vascular events and mental 
retardation. Mild elevations of homocysteine plasma levels up to 25 µM, which are 
common in the general population, are associated with vascular disease, cognitive 
impairment and neurodegeneration. Several mechanisms of homocysteine 
neurotoxicity have been investigated. However, information on putative effects of 
hyperhomocysteinemia on the electrophysiology of neurons is limited. To screen for 
such effects, we examined primary cultures of mouse hippocampal neurons with the 
whole-cell patch-clamp technique. Homocysteine was applied intracellularly (100 
µM), or cell cultures were incubated with 100 µM homocysteine for 24 h. Membrane 
voltage was measured in current-clamp mode, and action potential firing was induced 
with short and prolonged current injections. Single action potentials induced by short 
current injections (5 ms) were not altered by acute application or incubation of 
homocysteine. When we elicited trains of action potentials with prolonged current 
injections (200 ms), a broadening of action potentials during repetitive firing was 
observed in control neurons. This spike broadening was unaltered by acute 
application of homocysteine. However, it was significantly diminished when 
incubation with homocysteine was extended to 24 h prior to recording. Furthermore, 
the number of action potentials elicited by low current injections was reduced after 
long-term incubation with homocysteine, but not by the acute application. After 24 h 
of homocysteine incubation, the input resistance was reduced which might have 
contributed to the observed alterations in membrane excitability.  
We conclude that homocysteine impairs the electrophysiology of neurons as a 
mechanism of neurological symptoms of hyperhomocysteinemia.  
Introduction 
Homocysteine is a sulfur containing, reactive, non-proteinogenic amino acid 
occurring as ubiquitous intermediate of methionine metabolism. Depending on the 
cell type, homocysteine can be metabolized within, or released from the cell (Mudd et 
al. 2001). Several enzymes, transporter proteins and transmembrane carriers are 
involved in methionine-homocysteine metabolism, in which folate, riboflavin, vitamin 
B6 and vitamin B12 act as co-factors. Several hereditary enzyme defects and vitamin 
deficiencies can cause severe hyperhomocysteinemia, in which disulfides of 
homocysteine form homocystine. Because homocystine is renally excreted, this 
metabolic condition is denominated homocystinuria (Mudd et al. 2001). Neurological 
symptoms associated with untreated homocystinuria include psychomotor 
retardation, disturbances of central nervous system myelination and epilepsy (Mudd 
et al. 1985). Whereas homocysteine plasma levels in homocystinuric patients can 
reach 500 µM, mild hyperhomocysteinemia is defined by homocysteine plasma levels 
above the upper reference range of 10-15 µM up to 25 µM (Stanger et al. 2009). 
Polymorphic variants of proteins involved in homocysteine metabolism, vitamin 
deficiencies and renal dysfunction are common reasons of mild 
hyperhomocysteinemia (Mudd et al. 2001). Numerous studies investigated the 
relevance of mild hyperhomocysteinemia for central nervous system disorders. Mild 
hyperhomocysteinemia is associated not only with cerebrovascular disease, but also 
with mild cognitive impairment, Alzheimer’s disease and epilepsy (Stanger et al. 
2009). Moreover, the recent VITACOG trial showed a significant reduction in brain 
atrophy as effect of homocysteine-lowering vitamins in individuals with mild cognitive 
impairment (Smith et al. 2010). Thus, a causal relationship between homocysteine 
and neuronal damage may be assumed, but the underlying mechanisms remain 
speculative. Homocysteine acts as a partial antagonist of the glycine site of the N-
methyl-D-aspartate (NMDA) subtype of glutamate receptors, but is also an agonist at 
the glutamate binding site of this receptor. As NMDA receptors are up-regulated in 
alcohol-overconsuming individuals, because alcohol acts as an antagonist at NMDA 
receptors, elevated homocysteine plasma levels in actively drinking patients may 
contribute to seizures in alcohol withdrawal and explain the correlation between 
homocysteine plasma levels and the risk of withdrawal seizures (Bleich et al. 2006). 
Further, neuronal calcium influx mediated by effects of glutamatergic hyperexcitation 
of NMDA receptors is a pathomechanism of Alzheimer’s disease, and can induce cell 
death of retinal ganglion cells  (Ganapathy, 2011). Thus, the effect of homocysteine 
on NMDA receptors may also contribute to the association of hyperhomocysteinemia 
with mild cognitive impairment and dementia (Chan et al. 2008; Stanger et al. 2009; 
Smith et al. 2010). In the present study, we aimed at elucidating acute and chronic 
effects of homocysteine on the excitability of primary mouse hippocampal neurons.  
 
 Materials and methods 
Patch clamp recordings 
Primary cultured neurons were superfused with an extracellular solution containing 
(in mM): 125 NaCl, 3.5 KCl, 1.25 NaH2PO4, 2 MgSO4, 2 CaCl2, 26 NaHCO3, and 15 
D-glucose, osmolality 315 mOSm. Patch pipettes (resistance 3-4 MΩ) were filled with 
an intracellular solution containing (in mM) 130 K-gluconate, 20 KCl, 10 HEPES, 0.16 
ethylene glycol-bis (2-aminoethylether)-N,N,N',N'-tetraacetic acid (EGTA), 2 Mg-
adenosine 5'-triphosphate (ATP), and 2 Na2-ATP; pH was titrated to 7.25 with KOH; 
osmolality was adjusted to 295 mOsm using sucrose. 
A liquid junction potential of -15 mV was measured between the intra- and 
extracellular solutions and corrected so that the datapoints were shifted in a 
hyperpolarizing direction relative to the voltage axis. We obtained tight-seal whole-
cell recordings with an EPC9 amplifier (HEKA, Lamprecht, Germany). Voltage signals 
were filtered at 10 kHz (3 dB, four-pole low-pass Bessel filter) and sampled at 20 kHz 
or more by an interface (ITC16, Instrutech). All experiments were done at room 
temperature (21-23 °C). 
Neuronal Primary Cell Culture  
Primary hippocampal neurons were prepared from Wistar rats as described 
previously (Schoch et al., 2001). Pregnant rats were sacrificed, and the uterus 
containing the embryos (embryonic days 17-18) was removed. The hippocampus 
was isolated and the tissue was washed and then digested with trypsine (0.025 g/ml 
for 10 minutes at 37°C). After several washing steps, the tissue was dissociated by 
trituration using a plastic tip. The solution was centrifuged at 1,000 rpm for 10 
minutes and medium was added. After counting, the cells were plated at a density of  
40,000 / 24 well on glas coverslips coated with poly-L-lysine (Sigma-Aldrich). 
Neurons were cultured at 37°C in a humidified incubator with 95% air/5%CO2 in 
basal medium eagle (BME) supplemented with 0,5% glucose, 10% fetal calf serum 
(FCS), 2% B-27, and 0,5 mM L-glutamine (all Invitrogen, Karlsruhe, Germany) for 9-
14 days before use. 
Dissociated hippocampal neurons were incubated with 100 M homocysteine (DL-
Homocysteine, Sigma-Aldrich) for 24 h or were treated with acute intracellular 
application of 100 µM homocysteine via inclusion into the patch-pipette. All neurons 
used in our experiments had a pyramidal neuron-like morphology with one or two 
major dendrites emanating from the cell body. 
Analysis and statistics 
The analysis of the recorded traces was performed by an automated algorithm using 
the software Igor (Wavemetrics). The activation threshold of action potentials was 
determined as the point with the maximal increase of the slope. Parameters extracted 
from the traces were averaged and unpaired student’s-t-tests were performed for 
statistical comparison (Excel, Microsoft). The analysis was performed automated and 
blinded to avoid a bias. All data is presented as mean values, error bars represent 
the SEM. A significance level <0.05 is marked with asterisks throughout all figures. 
The number of recorded cells ranged from 10 to 20 (see figure legends for details).  
Results 
We obtained patch-clamp recordings from primary cultures of hippocampal neurons 
and first assessed the passive membrane properties of these neurons. No significant 
differences between the resting membrane potential of the cells could be observed 
when comparing cells cultured under control conditions, following incubation with 
homocysteine or during acute application of homocysteine (data not shown). We 
injected small subthreshold depolarizing currents to examine input resistance (Fig. 
1A, inset). Fitting the subthreshold current-voltage relation allowed us to determine 
the input resistance (Fig. 1A). We found that pre-incubation with homocysteine (24 h, 
see Methods) caused a pronounced reduction of the input resistance by 42% (Fig. 
1B, from 529 to 305 MΩ, n=10 and 10, p<0.05). In contrast, acute intracellular 
application of 100 µM homocysteine via inclusion into the patch-pipette did not affect 
input resistance (Fig. 1C, n=17 and n=16 for control and homocysteine).  
 
We next studied if the properties of action potentials are altered by homocysteine 
preincubation (Inc) or intracellular application of homocysteine (IC). Individual action 
potentials were elicited by brief current injections (5 ms, lowermost trace in Fig. 2A) 
elicited firing of single action potentials (uppermost trace in Fig. 2A). The threshold 
for generation of an action potential was unaffected by homocysteine, regardless of 
its mode of application (Fig. 2C), as was the action potential peak voltage (Fig. 2D), 
the time until the action potential peak was attained (Fig. 2E), and the duration of the 
action potential at threshold level (Fig. 2F). To examine spike afterpotentials, the 
depolarizing effects of the current injection were subtracted. To achieve this, we 
subtracted the voltage trace elicited by just subthreshold current injection (middle 
trace in Fig. 2A) scaled to the size of the initial depolarization preceding the action 
potential (dashed line in Fig. 2B). This revealed an after spike hyperpolarization 
(lowermost trace in Fig. 2B), which was also not altered by homocysteine pre-
incubation or intracellular application (Fig. 2G). Thus, it appears that neither 
application of homocysteine via the patch pipette nor 24 h pre-incubation with 
homocysteine modifies the properties of individual action potentials.  
 
We next studied the input-output relation of hippocampal neurons, and if this can be 
affected by homocysteine. The input-output relation was assessed by injecting 
current pulses of various amplitudes (200 ms, Fig. 3A, B, lowermost traces) and 
counting the number of resultant action potentials. We hypothesized that the 
decrease in input resistance seen in Fig. 1 would render homocysteine-pre-incubated 
neurons less excitable and reduce action potential output. Indeed, homocysteine-
preincubated cells generated significantly less action potential output for small 
current injections (100 and 150 pA, see Fig. 3C; asterisks indicate p<0.05, n=10 for 
homocysteine and control groups). Conversely, the application of homocysteine via 
the patch pipette did not affect the input-output relation (n=17 and n=16 for control 
and homocysteine, data not shown).  
 
To characterize the shape of the action potentials and their activity-dependent 
change during action potential trains, we analyzed the first voltage trace that 
displayed five action potentials. The action potential firing displayed a frequency 
adaptation during the train in control conditions (see Fig. 4A). This adaptation turned 
out to be significant when quantified as increasing interspike intervals for all recorded 
control cells (as indicates by the arrow in Fig. 4A, see filled circles and asterisks in 
Fig. 4B and C). Following 24h pre-incubation with homocysteine this frequency 
adaptation was markedly reduced and no longer significant (open circles in Fig. 4B). 
This was not the case when homocysteine was introduced via the patch-(open circles 
in Fig. 4C). Neither pre-incubation nor acute application of homocysteine affected the 
initial spike interval.  
 
Action potentials physiologically broaden during a train of action potentials, reflecting 
the progressive inactivation of voltage-gated ion channels (Fig. 5A). Spike 
broadening was quantified at the level of the half Ap amplitude (see dashed lines in 
Fig. 5B1 and B2). The spike broadening during trains was significantly reduced in 
cells pre-incubated 24 h in homocysteine (open circles in Fig. 5C). In contrast to the 
homocysteine effects on input resistance and frequency adaptation this loss of spike 
broadening was also exerted by acute application of homocysteine (open circles in 
Fig. 5D). These results show that long-term exposure to homocysteine strongly 
affects neuronal excitability whereas short-term exposure has only discrete effects. 
Discussion 
The present study aimed at analyzing electrophysiological effects of homocysteine as 
a possible mechanism of the association between hyperhomocysteinemia and 
neurological diseases.  
We tested the effects of intra- and extracellular elevations of homocysteine 
concentrations on primary mouse neurons, and observed that the input resistance 
decreases following long-term homocysteine exposure. This phenomenon results in a 
decrease of the neuronal input-output relation, rendering the neurons less excitable 
to lower- and mid-range current injections. Further, we found a significant reduction 
of both spike broadening and frequency adaptation during repetitive firing following 
24 h homocysteine incubation. While a reduction in input resistance may be 
interpreted as a reduction in excitability, this latter effect is consistent with an 
increased excitability, as spike accommodation limits the capability of cells to fire 
high-frequency discharges (Zhou and Hablitz 1996). These results indicate that the 
effects of homocysteine on neurons elude a simple classification into pro- and 
antiexcitatory effects.  
 
Homocysteine is associated with vascular and neurodegenerative diseases, 
mechanisms are only poorly understood. This study suggests that interaction of 
homocysteine with electrophysiological properties of cells may be a relevant 
mechanism. It remains unclear whether interaction with ion channels or ions 
themselves are the reason. We have shown that homocysteine and copper interact, 
probably by binding of copper by homocysteine (Linnebank et al. 2006). Thus, for the 
future, the channels and ions homocysteine is interfering with should be explored. As 
limitation, we used an artificial patch-clamp approach with experimental 24h-
incubation or intracellular application of homocysteine, whereas toxicity of mild or 
severe hyperhomocysteinemia occurs over years and decades.  As we aimed at 
analyzing toxicity of hyperhomocysteinemia as a chronic condition in humans, we did 
not analyze per-acute effects of homocysteine incubation, but incubated cells for 24h 
before testing as a compromise. Homocysteine is not taken up by cells, but can be 
excreted to the extracellular space (Fowler 2005). Thus, concerning intracellular 
application, we made analyses immediately, as intracellular concentrations after 
application were unpredictable and could not be monitored. 
 
In patients, available evidence suggests that hyperhomocysteinemia is associated 
with increased CNS excitability. For instance, hyperhomocysteinemia is a risk factor 
for epileptic seizures in alcohol dependent patients under conditions of alcohol 
withdrawal (Bleich et al. 2006). One explantion for this hyperexcitable phenotype in-
vivo may be that in intact neuronal networks, the proexcitatory effects of 
homocysteine dominate. Alternately, synaptic effects of homocysteine may become 
relevant. In the case of withdrawal seizures, NMDA receptors, which are inhibited by 
alcohol, are up-regulated in actively drinking patients. Homocysteine is both an 
agonist at the glutamate binding site of the NMDA receptor complex, and an 
antagonist at the glycine coagonist site. This raises the possibility that homocysteine 
may exert NMDA agonistic actions, in particular if glycine levels in the CNS are 
increased (Lipton et al. 1997; Bleich et al. 2006).  
 
Epilepsy is one of the most common neurological disorders. In most cases, a lifetime 
therapy with antiepileptic drugs (AED) is necessary. Despite development of a 
significant number of new AEDs, about 30% of patients with epilepsy remain 
refractory to drug treatment (Regesta and Tanganelli 1999). Even though drug 
resistance is a significant clinical problem, the molecular and cellular mechanisms 
underlying the clinical phenomenon of drug resistance remain incompletely 
understood. Most AED are associated with decreased folate or vitamin B12 plasma 
levels and thus dispose to hyperhomocysteinemia (Linnebank et al. 2011). 
Hyperhomocysteinemia due to AED long-term treatment may contribute to secondary 
pharmacoresistance observed in several patients with initial AED response. In 
addition, inhibitory and excitatory effects of hyperhomocysteinemia may contribute to 
long-term AED side-effects on the central nervous system like fatigue and cognitive 
impairment in addition to the increased risk for ischemic heart disease (+34%) and 
fatal cardiovascular disease (+68%) in individuals with epilepsy (Gaitatzis et al. 
2004).  
 
In conclusion, our data describe heterogeneous electrophysiological effects of 
homocysteine on neurons, some of which may contribute to neurological impairment 
and seizures associated with hyperhomocysteinemia.  
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Figure 1: Homocysteine effects on passive properties of 
hippocampal neurons  
A, Photomicrograph of a representative neuronal culture on the left. Right panel 
shows input resistance calculated according to Ohm’s law from the current-voltage 
relation of passive voltage deflections (see inset, scalebars indicate 5 mV and 20 ms) 
elicited by small subthreshold current injections. B, C, Pre-incubation with 
homocysteine (Inc, open bars in panel B, n=10), but not acute application of 
homocysteine (IC, open bars in panel C, n=16), resulted in a decreased input 
resistance compared to control cells (filled bars in panels B, n=10 and C, n=17). 
 Figure 2: Homocysteine does not affect the action potential shape 
A, Representative voltage trace of an action potential (upper trace) and a passive 
depolarization (middle trace, see lowermost part for current injections). C, D, E, F, G, 
Neither the action potential threshold (panel C), the minimum current injection 
needed to elicit an action potential (panel D), the peak voltage (panel D), the time to 
peak (panel E) nor the width of the action potential at threshold level (panel F) are 
altered following acute intracellular application (open bars, IC, n=15) or 24 h 
incubation (open bars, Inc, n=14) with 100 M homocysteine compared with control 
cells (filled bars n=16 (IC group) and 13 (Inc group)). B, To analyze the 
afterpotentials of the action potential the voltage trace elicited with a subthreshold 
current injection (panel A, middle trace) was scaled to fit the passive phase of the 
action potential trace (panel A, upper trace). The up-scaled subthreshold trace 
(dashed line) was subtracted from the action potential trace (full line) to correct the 
voltage trace for the artificial voltage deflection due to the experimental setup. The 
resulting trace (lowermost part) represents the active voltage changes during an 
action potential and reveals a pronounced afterspike hyperpolarization. G, The AHP 
was quantified in control cells (filled bars) and following intracellular application (IC) 
or 24 h incubation (Inc) with homocysteine (open bars) and was unaffected by 
homocysteine. 
 Figure 3: Reduced repetitive firing following homocysteine 
incubation 
A, Prolonged current injections (200 ms) of varying magnitude (50-400 pA) were 
applied to elicit repetitive action potential firing. B, Representative voltage traces 
recorded in control cells (panel B1) and following incubation with homocysteine (panel 
B2). C, The action potential frequency for all cells was depicted versus the magnitude 
of the current injection. In control cells (filled circles, n=10), the action potential firing 
rate increased initially with larger current injections (see also lower traces in panel 
B1). When further increasing the magnitude of the current injection, the repolarization 
became insufficient, and the action potential firing was blocked (see uppermost 
traces in panel B1) resulting in reduced firing rates. In homocysteine treated cells 
(open circles, n=10), the firing rate following small current injections was significantly 
smaller (see asterisks, p<0.05). With larger current injections, the firing rate 
increased continuously without block due to insufficient repolarization (see also upper 
traces in panel B2). 
  
Figure 4: Homocysteine abolishes the frequency adaptation of 
repetitive firing 
A, The first action potential train with at least 5 action potentials was analyzed to 
address the frequency adaptation during the train. Interspike intervals as indicated by 
the arrow were quantified. B, C, During the recorded period a slight but significant 
increase of the interspike interval was observed (filled circles in panels B, n=10 and 
panel C, n=17, p<0.05, see asterisks). Following 24h pre-incubation (Inc) with 
homocysteine this frequency adaptation was abolished (open circles in panel B, 
n=10, not significant) but it was not affected by acute intracellular application (IC) of 
homocysteine (panel C open circles, n=16). 
 
 Figure 5: Spike broadening is reduced following incubation with 
homocysteine 
A, To address the spike broadening during the train, the same traces as in Figure 3 
were analyzed. B, Action potential width was measured at halfwidth level (dashed 
horizontal line) as depicted for the first (panel B1 as indicated in panel A) and last 
action potential (panel B2 as indicated in panel A). C, D, Width of all action potentials 
was normlized to the width of the first action potential, averaged for all cells. In 
control cells, the spikes broadened to the ~1.5 width of the first action potential (filled 
circles in panel C, n=10 and panel D, n=17). This broadening was significantly 
reduced following 24 h incubation (Inc) with homocysteine (panel C, open circles, 
n=10), or acute application (IC) of homocysteine (panel D, open circles, n=16). 
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